Buscar
Mostrando ítems 1-5 de 5
Artículo
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
(Elsevier Science Inc., 2022)
Background Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and ...
Artículo
Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers
(Science Direct, 2022)
Purpose: Linkage between clinical databases and population-based cancer registries may serve to evaluate Eu ropean Reference Networks’ (ERNs) activity, by monitoring the proportion of patients benefiting from these and ...
Artículo
Nanomedicines and cell-based therapies for embryonal tumors of the nervous system
(Elsevier Science BV, 2022)
Embryonal tumors of the nervous system are neoplasms predominantly affecting the pediatric population. Among the most common and aggressive ones are neuroblastoma (NB) and medulloblastoma (MB). NB is a sympathetic ...
Artículo
Cáncer en los primeros 18 meses de vida
(Elsevier, 2020)
Artículo
Assessment of Waldeyer’s ring in pediatric and adolescent Hodgkin lymphoma patients—Importance ofmultimodality imaging: Results from the EuroNet-PHL-C1 trial
(WILEY-BLACKWELL, 2021)
Background: In the EuroNet Pediatric Hodgkin Lymphoma (EuroNet-PHL) trials, decision onWaldeyer’s ring (WR) involvement is usually based on clinical assessment, that is, physical examination and/or nasopharyngoscopy. ...